| 1. | 2024/12 |  | Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode. | 
          
            | 2. | 2024/12 |  | Efficacy and safety of intradialytic parenteral nutrition using ENEFLUID® in malnourished patients receiving maintenance hemodialysis: An exploratory, multicenter, randomized, open-label study. | 
          
            | 3. | 2024/11/29 |  | Baseline Characteristics of the DISCOVER CKD Prospective Cohort. | 
          
            | 4. | 2024/09 |  | Association between Timing of Vascular Access Creation and Mortality in Patients Initiating Hemodialysis: A Nationwide Cohort Study in Japan. | 
          
            | 5. | 2024/09 |  | Development of Artificial Intelligence Systems for Chronic Kidney Disease. | 
          
            | 6. | 2024/09 |  | Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging | 
          
            | 7. | 2024/08 |  | The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKD. | 
          
            | 8. | 2024/07 |  | Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database. | 
          
            | 9. | 2024/07 |  | Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. | 
          
            | 10. | 2024/06/28 |  | Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer   | 
          
            | 11. | 2024/05/20 |  | Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes. | 
          
            | 12. | 2024/05/08 |  | Factors affecting the sodium-glucose cotransporter2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidneydisease with type 2 diabetes: The Japan Chronic Kidney Disease Database
 | 
          
            | 13. | 2024/04/11 |  | Development of a prognostic risk score to predict early mortality in incident elderly Japanese hemodialysis patients. | 
          
            | 14. | 2024/03/13 |  | Mathematical expansion and clinical application of chronic kidney disease stage as vector field   | 
          
            | 15. | 2024/01/18 |  | New marker for chronic kidney disease progression and mortality in medical-word virtual space. | 
          
            | 16. | 2024 |  | Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study. | 
          
            | 17. | 2024 |  | Author Correction: Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial. | 
          
            | 18. | 2024 |  | Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort. | 
          
            | 19. | 2024 |  | Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis. | 
          
            | 20. | 2024 |  | Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial. | 
          
            | 21. | 2024 |  | eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR30 mL/min/1.73 m2 in the J-DREAMS cohort. | 
          
            | 22. | 2024 |  | Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. | 
          
            | 23. | 2024 |  | Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care. | 
          
            | 24. | 2024 |  | Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study. | 
          
            | 25. | 2024 |  | Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. | 
          
            | 26. | 2023/12/20 |  | Effect of decreased platelets on postoperative recurrence of chronic subdural hematoma. | 
          
            | 27. | 2023/07/19 |  | eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database   | 
          
            | 28. | 2023/06 |  | The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study   | 
          
            | 29. | 2023/01/13 |  | Preoperative elevated eosinophils in peripheral blood predicts recurrence of chronic subdural hematoma after surgery. | 
          
            | 30. | 2023/01/11 |  | Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers | 
          
            | 31. | 2023 |  | Association of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan. | 
          
            | 32. | 2023 |  | Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. | 
          
            | 33. | 2023 |  | Effect of overweight/obesity and metabolic syndrome on frailty in middle-aged and older Japanese adults. | 
          
            | 34. | 2023 |  | Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study. | 
          
            | 35. | 2023 |  | Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality. | 
          
            | 36. | 2023 |  | Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association. | 
          
            | 37. | 2022/12 |  | Nutritional Management in Elderly CKD Patients in Japan | 
          
            | 38. | 2022/11 |  | Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients. | 
          
            | 39. | 2022/11 |  | Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia. Nutrients. | 
          
            | 40. | 2022/09/12 |  | Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions | 
          
            | 41. | 2022/08/10 |  | Retrospective study on changes in renal function by treatment with two types of herbal medicines | 
          
            | 42. | 2022/06 |  | Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility | 
          
            | 43. | 2022/06 |  | Performance Status Modifies the Association Between Vitamin D Receptor Activator and Mortality or Fracture: A Prospective Cohort Study on the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry. | 
          
            | 44. | 2022/04/23 |  | Number of Children and Risk of Cardiovascular Disease in Japanese Women: Findings from the Tohoku Medical Megabank | 
          
            | 45. | 2022/04/06 |  | Evaluation of maxillary and mandibular growth patterns with cephalometric analysis based on cervical vertebral maturation: A Japanese cross-sectional study | 
          
            | 46. | 2022/04 |  | Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients | 
          
            | 47. | 2021/05/11 |  | Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.   | 
          
            | 48. | 2021/01/19 |  | Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study. | 
          
            | 49. | 2021/01 |  | Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A. | 
          
            | 50. | 2021 |  | Association between anemia and mortality in hemodialysis patients is modified by the presence of diabetes. | 
          
            | 51. | 2021 |  | High-performance dialyzers and mortality in maintenance hemodialysis patients | 
          
            | 52. | 2021 |  | Methods and Nutritional Interventions to Improve the Nutritional Status of Dialysis Patients in JAPAN | 
          
            | 53. | 2021 |  | Methods and rationale of the DISCOVER CKD global observational study | 
          
            | 54. | 2021 |  | Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A. | 
          
            | 55. | 2021 |  | The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patients. | 
          
            | 56. | 2020/12 |  | Optimal phase analysis of electrocardiogram-gated computed tomography angiography in patients with Stanford type A acute aortic dissection. | 
          
            | 57. | 2020/11/28 |  | Increased plasma plasmin-alpha2-plasmin inhibitor complex levels correlate with postoperative rebleeding after endoscopic surgery for spontaneous intracerebral hemorrhage. | 
          
            | 58. | 2020/10/17 |  | Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.   | 
          
            | 59. | 2020/10/15 |  | Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)   | 
          
            | 60. | 2020/07/20 |  | Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).   | 
          
            | 61. | 2020/05/29 |  | Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.   | 
          
            | 62. | 2020/01 |  | Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms.   | 
          
            | 63. | 2020 |  | 2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report | 
          
            | 64. | 2020 |  | Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study. | 
          
            | 65. | 2020 |  | J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan | 
          
            | 66. | 2020 |  | Postdialysis blood pressure is a better predictor of mortality than predialysis blood pressure in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study | 
          
            | 67. | 2020 |  | Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis. | 
          
            | 68. | 2020 |  | Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population. | 
          
            | 69. | 2020 |  | The Normalized Protein Catabolic Rate and Mortality Risk of Patients on Hemodialysis by Frailty Status: The Japanese Dialysis Outcomes and Practice Pattern Study | 
          
            | 70. | 2019/11/28 |  | Increased plasma plasmin-α2-plasmin inhibitor complex levels correlate with postoperative rebleeding after endoscopic surgery for spontaneous intracerebral hemorrhage. | 
          
            | 71. | 2019/10/16 |  | Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. | 
          
            | 72. | 2019/10 |  | Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan. | 
          
            | 73. | 2019/08 |  | Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes. | 
          
            | 74. | 2019/07 |  | Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease? | 
          
            | 75. | 2019/07 |  | Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.   | 
          
            | 76. | 2019/05/30 |  | Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan.   | 
          
            | 77. | 2019/01 |  | Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.   | 
          
            | 78. | 2019 |  | A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study. | 
          
            | 79. | 2019 |  | Identifying progressive CKD from healthy population using Bayesian network and artificial intelligence: A worksite-based cohort study. | 
          
            | 80. | 2019 |  | Relationship between Coombs-positive autoimmune hemolytic anemia and development of malignant tumors: a retrospective study | 
          
            | 81. | 2019 |  | Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study. | 
          
            | 82. | 2018/12 |  | Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices.   | 
          
            | 83. | 2018/11 |  | Kikuchi H, Kanda E, Mori T, Sato H, Iimori S, Nomura N, Naito S, Sohara E, Okado T, Uchida S, Fushimi K, Rai T. | 
          
            | 84. | 2018/11 |  | Patterns of adenoid and tonsil growth in Japanese children and adolescents: A longitudinal study | 
          
            | 85. | 2018/10 |  | Dialysate Calcium Concentration below 3.0 mEq/L Is Not Associated with Improved Outcomes in the Japanese Dialysis Outcomes and Practice Patterns Study. | 
          
            | 86. | 2018/09 |  | Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population.   | 
          
            | 87. | 2018/07 |  | SARCOPENIA AND FRAILTY IN PD: IMPACT ON MORTALITY, MALNUTRITION, AND INFLAMMATION. | 
          
            | 88. | 2018/07 |  | The effect of small dose of topiroxostat on serum uric acid in patients receiving hemodialysis. | 
          
            | 89. | 2018/04 |  | Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.   | 
          
            | 90. | 2018/04 |  | Interventional nephrology: current status and clinical impact in Japan. | 
          
            | 91. | 2018/04 |  | Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study. | 
          
            | 92. | 2018/03 |  | Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). | 
          
            | 93. | 2018/03 |  | Unexpected association between subclinical hearing loss and restorative sleep in a middle-aged and elderly Japanese population. | 
          
            | 94. | 2017/12 |  | Association of the Clinical and Genetic Factors With Superior Vena Cava Arrhythmogenicity in Atrial Fibrillation. | 
          
            | 95. | 2017/12 |  | Comparison of accuracy between pre-hemodialysis and post-hemodialysis levels of nutritional factors for prediction of mortality in hemodialysis patients. | 
          
            | 96. | 2017/09 |  | Factors associated with posttraumatic growth among parents of children with cancer. | 
          
            | 97. | 2017/08 |  | Differential changes in the adenoids and tonsils in Japanese children and teenagers: a cross-sectional study. | 
          
            | 98. | 2017/07 |  | Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study. | 
          
            | 99. | 2017/06 |  | The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE study. | 
          
            | 100. | 2017/05 |  | Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function. | 
          
            | 101. | 2017/03 |  | Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion. | 
          
            | 102. | 2017/02 |  | Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study. | 
          
            | 103. | 2017/02 |  | Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study. | 
          
            | 104. | 2017/02 |  | Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis. | 
          
            | 105. | 2016/11 |  | Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho. | 
          
            | 106. | 2016/08 |  | Prevalent hyperglycemia in older obese population and age-dependent convergence of obese indices: Results of a cross-sectional study of Japanese generations over the adult life span. | 
          
            | 107. | 2016/04 |  | Estimation of daily protein intake based on spot urine urea nitrogen concentration in chronic kidney disease patients. | 
          
            | 108. | 2016/01 |  | Latent association between low urine pH and low body weight in an apparently healthy population. | 
          
            | 109. | 2016/01 |  | The association of serum sodium and chloride levels with blood pressure and estimated glomerular filtration rate. | 
          
            | 110. | 2015/11 |  | Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort. | 
          
            | 111. | 2015/11 |  | Two Cases of Hemodialysis-associated Chronic Portal-systemic Shunt Encephalopathy (CPSE) with Opposite Changes in the Blood Ammonia Concentrations during Hemodialysis: A Case Report and Literature Review | 
          
            | 112. | 2015/09 |  | A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan | 
          
            | 113. | 2015/09 |  | Use of big data in medicine. | 
          
            | 114. | 2015/08 |  | Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study. | 
          
            | 115. | 2015/06 |  | Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns study. | 
          
            | 116. | 2015/02 |  | Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. | 
          
            | 117. | 2014/04 |  | Decreased mobility after starting dialysis is an independent risk factor for short-term mortality after initiation of dialysis. | 
          
            | 118. | 2014/04 |  | Subclinical hearing loss, longer sleep duration, and cardiometabolic risk factors in Japanese general population. | 
          
            | 119. | 2014/03 |  | Causes of fever in dialysis patients and its treatment | 
          
            | 120. | 2014/03 |  | Effects of sleepiness on survival in Japanese hemodialysis patients: J-DOPPS study. | 
          
            | 121. | 2014/02 |  | Dietary acid intake and kidney disease progression in the elderly. | 
          
            | 122. | 2013/10 |  | Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography. | 
          
            | 123. | 2013/10 |  | The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level. | 
          
            | 124. | 2013/07 |  | Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. | 
          
            | 125. | 2013/06 |  | Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis. | 
          
            | 126. | 2013/06 |  | Dyslipidaemia in patients with chronic kidney disease and treatment | 
          
            | 127. | 2013/03 |  | Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies. | 
          
            | 128. | 2013/01 |  | High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. | 
          
            | 129. | 2012/09 |  | Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. | 
          
            | 130. | 2011/05 |  | Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis. | 
          
            | 131. | 2008/08 |  | Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking. | 
          
            | 132. | 2008/04 |  | A familial case of mitochondrial disease resembling Alport syndrome. | 
          
            | 133. | 2007/10 |  | A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis. | 
          
            | 134. | 2007/07 |  | Progression of Kidney Failure in Patients with Non-diabetic Chronic Kidney Disease under Combination Therapy in Japan | 
          
            | 135. | 2007/01 |  | Fulminant pneumatosis intestinalis in a patient with diabetes mellitus and minimal change nephrotic syndrome. | 
          
            | 136. | 2005/06 |  | Tuberous sclerosis, associated with renal cell carcinoma and angiomyolipoma, in a patient who developed endstage renal failure after nephrectomy. | 
          
            | 137. | 2004/12 |  | A female patient with malarial nephropathy. | 
          
            | 138. | 2004/12 |  | Role of cytokines in anaphylactoid reaction with marked eosinophilia in a hemodialysis patient. | 
          
            | 139. | 2003/02 |  | Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells. | 
          
            | 140. | 2002/04 |  | Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. | 
          
            | 141. | 2001/08 |  | CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling. | 
          
            | 142. | 2001/07 |  | Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk. | 
          
            | 143. | 2001/03 |  | Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. | 
          
            | 144. | 2001/01 |  | IgA nephropathy with complement deficiency | 
          
  | Display 5 items | 
  | Display all(144) |